Lorelei Ann Fen , APN
Nurse Practitioner • Pompton Plains, NJ
97 W Parkway
Pompton Plains, NJ 07444
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on February 13, 2007; this date does not establish years in practice.
-
Published CMS data list 913 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Anastrozole — 163 prescription fills, including refills.
- Warfarin Sodium — 86 prescription fills, including refills.
- Dexamethasone — 58 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in New Jersey (2024, 875 clinicians with data). Median for this group: 308. Middle half: 81 to 1,016.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 23 in 2020 to 913 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
97 W Parkway
Pompton Plains, NJ 07444
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Regional Cancer Care Associates Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2001
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,612 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,292,375 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $343.95 across 19 records.
By nature of payment
- Food and Beverage: $343.95 across 19 records.
Reporting-company totals (3 largest of 15)
- AstraZeneca Pharmaceuticals LP: $53.54 across 3 records.
- Novartis Pharmaceuticals Corporation: $35.97 across 2 records.
- GlaxoSmithKline, LLC.: $35.10 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Lorelei Fen has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Lorelei Fen as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Pompton Plains and New Jersey
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in New Jersey (2024, 875 clinicians with data). Median for this group: 308. Middle half: 81 to 1,016.
Too few clinicians listed under Nurse Practitioner in Pompton Plains have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner in New Jersey (2024, 875 clinicians with data). Median for this group: $22,535. Middle half: $1,330 to $113,516.
Too few clinicians listed under Nurse Practitioner in Pompton Plains have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Nurse Practitioner with a practice address in Pompton Plains, NJ (1,964 in New Jersey).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 3870% from 23 in 2020 to 913 in 2024.
- 2020: 23
- 2021: 15
- 2022: 744
- 2023: 910
- 2024: 913
-
30-day fills
30-day fills increased 6907% from 23 in 2020 to 1,612 in 2024.
- 2020: 23
- 2021: 15
- 2022: 1,395
- 2023: 1,562
- 2024: 1,612
-
Part D drug cost
Part D drug cost went from $501 in 2020 to $2,292,375 in 2024.
- 2020: $501
- 2021: $129
- 2022: $1,279,702
- 2023: $1,896,738
- 2024: $2,292,375
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $230.56 in 2021 to $343.95 in 2025.
- 2021: $230.56
- 2023: $213.56
- 2024: $200.10
- 2025: $343.95
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 19 records totaling $343.95.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $21.78 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $21.02 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
DARZALEX | General | $20.30 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ENHERTU | General | $19.77 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
OJJAARA | General | $19.61 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $19.44 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ICLUSIG | General | $19.38 |
| Legend Biotech USA Inc. |
Food and Beverage
In-kind items and services
|
CARVYKTI | General | $18.66 |
| Agios Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PYRUKYND | General | $18.36 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KISQALI | General | $18.20 |
| TerSera Therapeutics LLC |
Food and Beverage
In-kind items and services
|
Xermelo | General | $18.14 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KISQALI | General | $17.77 |
| PharmaEssentia USA Corporation |
Food and Beverage
In-kind items and services
|
BESREMI | General | $17.60 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $17.03 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $16.74 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
EPKINLY | General | $15.90 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
OJJAARA | General | $15.49 |
| Invivyd Inc |
Food and Beverage
In-kind items and services
|
PEMGARDA | General | $14.87 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
OPDIVO | General | $13.89 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Anastrozole | Anastrozole | 163 | 13,587 | $3,960.51 | 93 |
| Warfarin Sodium | Warfarin Sodium | 86 | 5,147 | $936.90 | 23 |
| Dexamethasone | Dexamethasone | 58 | 1,771 | $797.42 | 21 |
| Eliquis | Apixaban | 56 | 2,513 | $48,650.45 | 25 |
| Letrozole | Letrozole | 49 | 3,650 | $1,045.68 | 25 |
| Prednisone | Prednisone | 44 | 1,298 | $254.21 | 26 |
| Hydroxyurea | Hydroxyurea | 44 | 2,921 | $1,015.24 | 23 |
| Xarelto | Rivaroxaban | 38 | 2,280 | $41,472.99 | 17 |
| Acyclovir | Acyclovir | 38 | 1,800 | $880.51 | 17 |
| Ondansetron Odt | Ondansetron | 30 | 232 | $306.87 | 20 |
| Venclexta | Venetoclax | 28 | 810 | $301,978.45 | — |
| Tamoxifen Citrate | Tamoxifen Citrate | 25 | 1,970 | $748.97 | 16 |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 23 | 232 | $311.21 | 15 |
| Revlimid | Lenalidomide | 20 | 560 | $355,327.22 | — |
| Exemestane | Exemestane | 20 | 1,260 | $1,591.58 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 19 | 900 | $118.04 | 13 |
| Imatinib Mesylate | Imatinib Mesylate | 18 | 540 | $55,939.96 | — |
| Gabapentin | Gabapentin | 17 | 635 | $105.91 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 17 | 286 | $311.02 | — |
| Brukinsa | Zanubrutinib | 17 | 510 | $236,627.23 | — |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | 365 | $170.98 | — |
| Jakafi | Ruxolitinib Phosphate | 15 | 450 | $231,097.40 | — |
| Imbruvica | Ibrutinib | 15 | 420 | $238,506.20 | — |
| Lorazepam | Lorazepam | 12 | 155 | $41.69 | — |
| Promacta | Eltrombopag Olamine | 12 | 356 | $149,272.45 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20180725000826
NJ
9032466800
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Regional Cancer Care Associates Llc
97 W Pkwy, Pompton Plains, NJ 074441647
Phone: 9738315000
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Hematology & Oncology
Doctor of Osteopathic Medicine (D.O.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 97 W PARKWAY, POMPTON PLAINS, NJ 07444 (Tel: 9738315451)
Recorded as LORELEI FEN, APN
NPI status registered as active in NPPES database
Registered at 97 W PARKWAY, POMPTON PLAINS, NJ 074441647 (Tel: 9738315451)
Registered at 97 W PARKWAY, POMPTON PLAINS, NJ 074441647 (Tel: 9738315451)
Recorded as LORELEI ILEDAN FEN, RN, APN-C
Nurse Practitioner (license number reported to NPPES: NJ 26NN10044200)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Pompton Plains
Healthcare providers in Pompton PlainsMailing Address
97 W Parkway
Pompton Plains, NJ 074441647
Phone: 9738315451